National rotavirus vaccination programme implementation and gastroenteritis presentations: the paediatric emergency medicine perspective
- PMID: 31197576
- DOI: 10.1007/s11845-019-02046-z
National rotavirus vaccination programme implementation and gastroenteritis presentations: the paediatric emergency medicine perspective
Abstract
Background: Throughout the developed world, the introduction of rotavirus vaccination has led to reductions in the incidence and severity of acute gastroenteritis (AGE) in young children and consequently to reductions in paediatric emergency department (PED) attendances with AGE. Rotavirus vaccination was added to the Irish National Immunisation Schedule in November 2016.
Aims: To assess the impact of vaccine introduction on citywide PED attendances and hospital admissions with all-cause AGE during rotavirus season.
Methods: In an observational study, a retrospective search was performed of electronic records in three independent PEDs in Dublin. Weekly presentations and admissions with AGE in the first 30 weeks (gastroenteritis season) of the years 2012-2018 were counted and stratified by age.
Results: Median weekly presentations in 2017-2018, 126 (interquartile range (IQR) 103-165) were significantly lower than in 2012-2016, 160 (IQR 128-214) (p < 0.001). A reduction in presentations was seen across the three hospitals and in those aged less than 5 years. In one PED, median admissions in 2017-2018 were 10 (IQR 7-13) in comparison with nine (IQR 7-13) in 2012-2016, (p = 0.463). The emergency department AGE presentations to hospital ward admission rate was 6.7:1.
Conclusion: A reduction in PED presentations with AGE is demonstrated post-rotavirus vaccine introduction into the Irish National Immunisation Schedule. No significant change in paediatric hospital admissions was demonstrated.
Keywords: Acute gastroenteritis; Paediatric emergency medicine; Rotavirus; Rotavirus vaccination.
Similar articles
-
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Pediatr Infect Dis J. 2011. PMID: 21183837
-
Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.Euro Surveill. 2015;20(48):30077. doi: 10.2807/1560-7917.ES.2015.20.48.30077. Euro Surveill. 2015. PMID: 26675375
-
Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.Vaccine. 2017 Jan 23;35(4):680-686. doi: 10.1016/j.vaccine.2016.11.057. Epub 2016 Dec 20. Vaccine. 2017. PMID: 28007397 Free PMC article.
-
Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.BMC Infect Dis. 2017 Aug 15;17(1):569. doi: 10.1186/s12879-017-2613-4. BMC Infect Dis. 2017. PMID: 28810833 Free PMC article.
-
Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.Expert Opin Biol Ther. 2013 Nov;13(11):1613-21. doi: 10.1517/14712598.2013.840285. Epub 2013 Oct 2. Expert Opin Biol Ther. 2013. PMID: 24088009 Review.
Cited by
-
Group A Rotavirus Detection and Genotype Distribution before and after Introduction of a National Immunisation Programme in Ireland: 2015-2019.Pathogens. 2020 Jun 7;9(6):449. doi: 10.3390/pathogens9060449. Pathogens. 2020. PMID: 32517307 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical